All lobbying filings
Endgame Strategies, LLC
Endgame Strategies, LLC filed a Q3 termination report for Association of Accessible Medicines on September 23, 2025, reporting $40,000 in lobbying income.
Lobbying for Association of Accessible Medicines · Trade association working to ensure generic and biosimilar medicines are more accessible.
Filing · LD-2 quarterly report
Q3 termination
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Sep 23, 2025
Income
$40,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Representation ended
Sep 5, 2025
The registrant reported terminating its work for this client.
Lobbyists on this filing
1
-
STEVEN DUFFIELDPreviously held: Senate Republican Conference (Policy Director); Senate Republican Policy Committee (Deputy Staff Director; Chief Counsel; Judiciary Policy Analyst)
Government bodies contacted
2
Lobbying activity
2
Issues relating to patent policy and drug pricing, and legislative proposals relating to Patent Trial & Appeal Board and patent eligibility.
Issues relating to patent policy and drug pricing